Clinical Trial Update: Dose Finding Study for QAW039 in Asthma [Phase 2]

View source ↗

Summary

Phase 2 dose-finding study for QAW039 in asthma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• QAW039

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Asthma | Phase 2 | Status: COMPLETED